Control Bionics Limited (ASX:CBL)
0.0550
-0.0030 (-5.17%)
Mar 18, 2026, 3:58 PM AEST
Control Bionics Revenue
Control Bionics had revenue of 2.82M AUD in the half year ending December 31, 2025, a decrease of -4.86%. This brings the company's revenue in the last twelve months to 6.07M, up 14.88% year-over-year. In the fiscal year ending June 30, 2025, Control Bionics had annual revenue of 6.14M with 14.84% growth.
Revenue (ttm)
6.07M
Revenue Growth
+14.88%
P/S Ratio
3.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 6.14M | 794.13K | 14.84% |
| Jun 30, 2024 | 5.35M | -291.61K | -5.17% |
| Jun 30, 2023 | 5.64M | 1.14M | 25.33% |
| Jun 30, 2022 | 4.50M | 413.43K | 10.11% |
| Jun 30, 2021 | 4.09M | 886.39K | 27.68% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 33.05M |
| CleanSpace Holdings | 20.66M |
| Micro-X | 16.90M |
| ImpediMed | 14.23M |
| CurveBeam AI | 12.15M |
| CONNEQT Health | 5.80M |
| Atomo Diagnostics | 3.92M |
| OncoSil Medical | 3.72M |